Page 436 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 436

420            PART 6  ■  Neoplastic Disorders







                                                                                                                                BOX  22.2






                                                                                                                              Differential Diagnosis of Chronic

                                                                                                                              Lymphocytic Leukemia



                                                                                                                              BENIGN CAUSES
                                                                                                                               -Cell Associated


                                                                                                                              ■   B  cteri  l, e.g.,   B

                                                                                                                              ■   Vir  l, e.g., in ectious   ononucleosis


                                                                                                                              B-Cell Associated

                                                                                                                              ■   Persistent polyclon  l B-cell ly  phocytosis


                                                                                                                              ■   Hyperre  ctive     l  ri  l spleno  eg  ly


                                                                                                                              MALIGNANT B CELL

                                                                                                                              ■   Monoclon  l B-cell ly  phocytosis

                                                                                                                              ■   Proly  phocytic leuke  i   (PLL)

                                                                                                                              ■   H  iry cell leuke  i


               FIGURE 22.1  Chronic ly  phocytic leuke  i  . M  ture cells pre-                                               ■   Leuke  ic ph  se o  non-Ho  gkin ly  pho

                 o  in  te in the chronic leuke  i  s. In this bloo   s  e  r,    typic  l                                             Follicul  r ly  pho
               incre  se in the nu  ber o  s  u  ge cells is seen. (Si  ul  tes     gni-                                               M  ntle cell ly  pho

               f c  tion 1,000×.)                                                                                                      M  rgin  l zone ly  pho

                                                                                                                                       Ly  phopl  s    cytic ly  pho
                                                                                                                                       Di  use l  rge cell ly  pho

               Decision to Treat
                                                                                                                              MALIGNANT T CELL
               T e   ecision to tre  t    p  tient   epen  s on the st  ge o  the                                                 Proly  phocytic leuke  i

                 ise  se,  the presence o  sy  pto  s,    n   the   ise  se   ctiv-                                           ■   A  ult   -cell leuke  i  /ly  pho

               ity. Only p  tients in R  i III   n   IV or Binet C st  ges shoul                                              ■   Séz  ry syn  ro  e

               be tre  te  . P  tients in e  rly st  ges o  CLL shoul   only be                                               ■   L  rge gr  nul  r ly  phocytic leuke  i

               tre  te   i  sy  pto  s   ssoci  te   with the   ise  se occur (e.g.,                                          ■

               thre  tening co  plic  tions  ro   spleen or liver enl  rge  ent                                               Re erence: Greer JP, et   l. (e  .), Wintrobe’s Clinical Hematology, 13th e  ,

                 n   ly  pho    s th  t c  n pro  uce co  pression o  the l  rge                                              2014:1903.

                 b  o  in  l vessels). High   ise  se   ctivity is   ef ne   by    ly  -

               phocyte   oubling ti  e o  less th  n 6   onths or by r  pi  ly

               growing ly  pho    s. High   ise  se   ctu  lly is   lso   n in  ic  -

               tion to tre  t in the e  rly st  ges o  the   ise  se.                                                      cyclophosph    i  e. T is pro  uce      response in up to 70%

                                                                                                                           o  p  tients but   i   not i  prove surviv  l. Co  plete re  is-
               Historical Treatm ents                                                                                      sions   re r  re,   n   p  rti  l re  issions   re o  short   ur  tion.


               Origin  lly, the f rst-line tre  t  ent o  CLL in the 1960s con-                                                 Nucleosi  e (purine)   n  logues,  or ex    ple,   u    r  bine,

               siste   o    lkyl  ting   gents,  or ex    ple,  chlor    bucil   n                                         pentost  tin,   n   cl    ribine, th  t were popul  r in the 1980s











































                                    FIGURE 22.2    wo sli  es showing chronic ly  phocytic leuke  i  . (Reprinte    ro   An  erson S, Poulsen K.
                                    Anderson’s Atlas o  Hematology, Phil    elphi  , PA: Lippincott Willi    s & Wilkins, 2003, with per  ission.)
   431   432   433   434   435   436   437   438   439   440   441